Larimar Therapeutics Inc.

LRMR | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.83

+$0.04 (+1.06%)

At close: Sep 21, 2026, 4:00 PM ET

$3.83

$0 (0.00%)

Pre-market: Sep 22, 2026, 8:05 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	85.41M	33.22M	26.75M	26.83M	70.1M	68.15M
Short-Term Investments	51.44M	150.24M	60.04M	91.6M	n/a	24.49M
Long-Term Investments	n/a	n/a	1.34M	n/a	1.34M	n/a
Other Long-Term Assets	1.13M	1.2M	659K	1.98M	669K	1.76M
Receivables	747K	1.05M	332K	n/a	208K	32K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	253K	517K	377K	238K	279K	251K
Total Current Assets	142.02M	195.3M	90.18M	120.74M	72.2M	97.95M
Property-Plant & Equipment	2.69M	3.72M	3.76M	3.69M	4.46M	4.98M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	3.82M	4.92M	5.76M	5.67M	6.46M	6.73M
Total Assets	145.84M	200.23M	95.94M	126.41M	78.67M	104.69M
Account Payables	5.22M	2.42M	1.28M	1.69M	1.66M	2.63M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	1.11M	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	54.69M	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	64.8M	24.36M	9.51M	10.71M	8.85M	8.99M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	2.96M	4.06M	4.71M	4.8M	5.41M	6M
Total Liabilities	67.76M	28.41M	14.22M	15.5M	14.25M	14.99M
Total Debt	4.07M	5.12M	5.55M	5.41M	6M	6.52M
Book Value	78.09M	171.81M	81.72M	110.9M	64.41M	89.69M
Book Value Per Share	1.07	2.80	1.86	4.31	3.75	7.55
Common Stock	83K	64K	43K	43K	18K	15K
Retained Earnings	-434.83M	-269.16M	-188.55M	-151.61M	-116.25M	-65.61M
Comprehensive Income	54K	148K	81K	-31K	n/a	1K
Shareholders Equity	78.09M	171.81M	81.72M	110.9M	64.41M	89.69M
Total Investments	51.44M	150.24M	61.38M	91.6M	1.34M	24.49M